Jeux Olympiques de Paris 2024 : Une analyse certainement un peu biaisée.
SPECIAL REPORT 24.08 Jeux Olympiques de Paris 2024: Une analyse certainement un peu biaisée.
Latest
EMA does not recommend Leqembi for the treatment of Alzheimer’s disease
SPECIAL REPORT 24.07
EMA does not recommend Leqembi for the treatment of Alzheimer’s disease
On July 25, the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) recommended against marketing authorisation of BioArtic, Eisai and Biogen’s Lequembi, or lecanemab, an amyloid antibody
Eli Lilly wins FDA approval for donanamab
After decades of trying to develop a treatment for Alzheimer’s disease, Eli Lilly has finally won FDA approval for its drug donanemab, which will be marketed as Kisunla.
An approval was originally expected late last year, but it was delayed twice, including after regulators called for an 11th-hour meeting
Le système des retraites en France
Le système des retraites en France, repose sur un système simple et néanmoins original : celui de la répartition.
FDA Advisory Committee recommends approval of Eli Lilly donanemab
SPECIAL REPORT 24.06
US FDA Advisory Committee recommends approval of Eli Lilly donanemab
On June 10, 2024, the US FDA Peripheral and Central Nervous System Drugs Advisory Committee panel recommended approval of Eli Lilly’s donanemab for the treatment of early-stage Alzheimer’s disease.
The panel voted 11-0 that
Les Thérapeutiques de la Maladie D’Alzheimer
Congrès SDS: Le Cerveau dans tous ses Etats ( Marseille, le 31 mai 2024) Les Thérapeutiques de la Maladie D’Alzheimer: Faits, Tendances et Obstacles.
Oil and semiconductors: a story that repeats itself but is not the same.
By Jean-Claude Muller and John-Guy Park
Summary
"Oil and semiconductors: a story that repeats itself but is not the same"explores the parallels between oil and semiconductors, two crucial resources that have shaped not only technology and industry, but also global geopolitics. Oil, long considered the lifeblood of